Nolvadex/Tamoxifen (Tamox) is a selective estrogen receptor modulator (SERM). A SERM is an antagonist of estrogen receptors in the body, but also with some agonist action as well. Tamox is mostly researched for its anti-estrogenic actions which it exhibits by binding to some (not all) receptors in place of estrogen. This leads to a lessened estrogenic effect in those tissues and has led to its spread use in breast cancer and Gynecomastia research.

Tamox has also shown a very positive effect on luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone and sperm concentrations. This is big news for Infertility research and treatment. LH and FH play a big role in the development of sperm and testosterone. Without these hormones properly functioning at their correct levels a loss of fertility may be seen, along with declined Testosterone levels. Tamox has shown very promising in research for this effect along with its anti-estrogenic effects in selective tissues.

We are proud to over you only the highest quality Tamox for all your research needs.


Ref:
1) Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.Kunath F, Keck B, Antes G, Wullich B, Meerpohl JJ. http://www.ncbi.nlm.nih.gov/pubmed/22925442
2) Gynecomastia: physiopathology, evaluation and treatment.Barros AC, Sampaio Mde C. http://www.ncbi.nlm.nih.gov/pubmed/22790552
3) A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia.Serretta V, Altieri V, Morgia G, Nicolosi F, De Grande G, Mazza R, Melloni D, Allegro R, Ferraù F, Gebbia V. http://www.ncbi.nlm.nih.gov/pubmed/22502790
4) Gynecomastia - evaluation and current treatment options.Johnson RE, Kermott CA, Murad MH. http://www.ncbi.nlm.nih.gov/pubmed/21479145
5) [Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia].Tang KF, Xing Y, Wu CY, Liu RZ, Wang XY, Xing JP. http://www.ncbi.nlm.nih.gov/pubmed/21823344
6) Menstruation recovery after chemotherapy and luteinizing hormone-releasing hormone agonist plus tamoxifen therapy for premenopausal patients with breast cancer.Sakurai K, Matsuo S, Enomoto K, Amano S, Shiono M. http://www.ncbi.nlm.nih.gov/pubmed/21191690
7) Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.Franco JG Jr,